Mankind Pharma has successfully concluded its annual secretarial compliance review for the financial year ending March 31, 2026. The comprehensive audit, conducted by M/s Amit Gupta & Associates, confirms that the company has adhered to all necessary statutory provisions and corporate governance standards throughout the year. The report ensures transparency and accountability, reinforcing the company’s commitment to maintaining rigorous regulatory standards and operational excellence for its stakeholders.
Commitment to Corporate Governance
Mankind Pharma has successfully completed its mandatory secretarial audit for the fiscal year 2025-26. This process underscores the company’s unwavering commitment to ethical business practices and high standards of corporate governance. The independent review, performed by practicing professionals, serves as a vital component of the company’s transparency framework, validating that internal processes and regulatory filings remain in full alignment with established best practices.
Audit Findings and Compliance Status
The secretarial compliance report confirms that for the period ended March 31, 2026, Mankind Pharma has demonstrated consistent compliance across all applicable legal and operational requirements. The audit evaluated key areas including internal policy adoption, timely disclosures, and adherence to secretarial standards. No instances of non-compliance were observed during the review, reflecting a robust internal monitoring system that ensures consistent adherence to required protocols.
Strategic Transparency
By conducting and publicizing this review, Mankind Pharma reinforces trust with its investors and stakeholders. The company remains dedicated to the effective management of its affairs, ensuring that all policies—ranging from performance evaluations to related party transactions—are managed with strict oversight. This annual exercise is part of a broader strategy to uphold the highest levels of corporate integrity as the company continues to grow its market presence.
Source: BSE
